117 related articles for article (PubMed ID: 18413774)
1. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
Press OA; Zhang W; Gordon MA; Yang D; Lurje G; Iqbal S; El-Khoueiry A; Lenz HJ
Cancer Res; 2008 Apr; 68(8):3037-42. PubMed ID: 18413774
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
[TBL] [Abstract][Full Text] [Related]
4. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
[TBL] [Abstract][Full Text] [Related]
6. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy.
Zhou B; Rao L; Peng Y; Zhang Q; Zhang L
Clin Chim Acta; 2009 May; 403(1-2):184-7. PubMed ID: 19265688
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.
Brandt B; Meyer-Staeckling S; Schmidt H; Agelopoulos K; Buerger H
Clin Cancer Res; 2006 Dec; 12(24):7252-60. PubMed ID: 17189396
[TBL] [Abstract][Full Text] [Related]
9. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
[TBL] [Abstract][Full Text] [Related]
10. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
11. Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma.
Suzuki M; Kageyama S; Shinmura K; Okudela K; Bunai T; Nagura K; Igarashi H; Kiyose S; Mori H; Tao H; Goto M; Takamochi K; Mochizuki T; Suzuki K; Ohashi R; Ogawa H; Yamada T; Niwa H; Tsuneyoshi T; Sugimura H
J Surg Oncol; 2008 Nov; 98(6):457-61. PubMed ID: 18683191
[TBL] [Abstract][Full Text] [Related]
12. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.
Buerger H; Packeisen J; Boecker A; Tidow N; Kersting C; Bielawski K; Isola J; Yatabe Y; Nakachi K; Boecker W; Brandt B
J Pathol; 2004 May; 203(1):545-50. PubMed ID: 15095477
[TBL] [Abstract][Full Text] [Related]
13. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
14. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
15. Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.
Press OA; Zhang W; Gordon MA; Yang D; Haiman CA; Azuma M; Iqbal S; Lenz HJ
Pharmacogenomics J; 2011 Oct; 11(5):375-82. PubMed ID: 20548329
[TBL] [Abstract][Full Text] [Related]
16. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.
Buerger H; Gebhardt F; Schmidt H; Beckmann A; Hutmacher K; Simon R; Lelle R; Boecker W; Brandt B
Cancer Res; 2000 Feb; 60(4):854-7. PubMed ID: 10706093
[TBL] [Abstract][Full Text] [Related]
17. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
[TBL] [Abstract][Full Text] [Related]
18. Impact of EGFR genetic variants on glioma risk and patient outcome.
Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.
Lurje G; Hendifar AE; Schultheis AM; Pohl A; Husain H; Yang D; Manegold PC; Ning Y; Zhang W; Lenz HJ
Pharmacogenet Genomics; 2009 Feb; 19(2):95-102. PubMed ID: 18987561
[TBL] [Abstract][Full Text] [Related]
20. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.
Dassoulas K; Gazouli M; Rizos S; Theodoropoulos G; Christoni Z; Nikiteas N; Karakitsos P
Mol Carcinog; 2009 Jun; 48(6):563-9. PubMed ID: 19009560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]